Vienna Versus SARS-CoV-2 Virus Study (VIVI)

Medical University of Vienna

Status: Unknown

Conditions: COVID-19; SARS-CoV-2

Treatments: Diagnostic Test: Laboratory Analyses

Study type: Observational

Funder types: Other

Identifiers

NCT04407429

EK 1387/2020

Details and patient eligibility

About

This study examines the seroprevalence against SARS-CoV-2 in health care workers and patients at the Vienna General Hospital.

Full description

This study consists of 2 parts: a longitudinal study enrolling 3,000 health care professionals at the Vienna General Hospital testing their antibody status 6 times over a period of 12 months (Cohort A), and a serial cross-sectional study of 3,000 patients (i.e., a total of 9,000 patients) admitted to the Vienna General Hospital for non-COVID-19-related symptoms at 3 different time points during this pandemic (Cohort B).

Enrollment: 12,000 estimated patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Cohort A:

Inclusion criteria:

• Physicians
• Nursing staff
• Midwives
• Medical-technical assistants (including medical, therapeutic and diagnostic healthcare staff, and medical and nursing assistants)
• Administrative personnel with patient contact

Exclusion Criteria:

• Not employed at the Medical University of Vienna or the Vienna General Hospital
• No signed informed consent

Cohort B:

Inclusion Criteria:

● Patients with available residual serum samples

Exclusion Criteria:

● Serum samples from COVID-19 triage units at the Vienna General Hospital

Trial design

12,000 participants in 2 patient groups

Health care workers

Description:

Physicians, Nursing staff, Midwives, Medical-technical assistants (including medical, therapeutic and diagnostic healthcare staff, and medical and nursing assistants), administrative personnel with patient contact

Treatment:

Diagnostic Test: Laboratory Analyses

Patients

Description:

Patients admitted for non-COVID related symptoms to the Vienna General Hospital with available residual serum samples.

Treatment:

Diagnostic Test: Laboratory Analyses